Global Veterinary Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
SKU ID :Maia-20923201 | Published Date: 12-May-2022 | No. of pages: 108Description
An animal drug (also veterinary drug) refers to a drug intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals.
The Veterinary Drugs market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Veterinary Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Veterinary Drugs market.
Major Players in the Veterinary Drugs market are:
Merck Animal Health
Koninklijke DSM N.V
Ceva Sant Animale
Cargill Inc. (Provimi)
Vetoquinol
Dechra Pharmaceuticals PLC.
Nutreco N.V.
Boehringer Ingelheim GmbH
Sanofi S.A. (MERIAL Limited).
Evonik Industries AG
ADM Alliance Nutrition
Bayer AG
Elanco Animal Health (Eli Lilly and Company)
Zoetis, Inc. (Pfizer)
Virbac
On the basis of types, the Veterinary Drugs market is primarily split into:
Anti-Infective
Anti-Inflammatory
Parasiticides
Others
On the basis of applications, the market covers:
Veterinary Hospital Pharmacies
Retail Veterinary Pharmacies
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
2021
The Veterinary Drugs market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Veterinary Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Veterinary Drugs market.
Major Players in the Veterinary Drugs market are:
Merck Animal Health
Koninklijke DSM N.V
Ceva Sant Animale
Cargill Inc. (Provimi)
Vetoquinol
Dechra Pharmaceuticals PLC.
Nutreco N.V.
Boehringer Ingelheim GmbH
Sanofi S.A. (MERIAL Limited).
Evonik Industries AG
ADM Alliance Nutrition
Bayer AG
Elanco Animal Health (Eli Lilly and Company)
Zoetis, Inc. (Pfizer)
Virbac
On the basis of types, the Veterinary Drugs market is primarily split into:
Anti-Infective
Anti-Inflammatory
Parasiticides
Others
On the basis of applications, the market covers:
Veterinary Hospital Pharmacies
Retail Veterinary Pharmacies
Major Region
s or countries covered in this report:United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years:
2017-2021Base Year:
2021Estimated Year:
2022Forecast Period:
2022-2029TOC
Tables & Figures
Companies
- PRICE
-
$3450$6900$4600Buy Now